Inovio announces partial hold on Covid-19 vaccine candidate trial over FDA queries
This article was originally published here
The company’s investigational new drug application (IND) for the clinical trial will be on partial clinical hold until the regulator receives satisfying answers for the questions. The partial
The post Inovio announces partial hold on Covid-19 vaccine candidate trial over FDA queries appeared first on Pharmaceutical Business review.
Leave a Reply
Want to join the discussion?Feel free to contribute!